Combined Clozapine and Electroconvulsive Therapy in a Japanese Schizophrenia Patient: A Case Report
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Clozapine is well-known for successful use in schizophrenic patients treatment resistant to other antipsychotics. However, evenwith clozapine, 25% of schizophrenic patients are not in remission. Recently, as adjunctive treatment with clozapine, electroconvulsivetherapy has been reported to be an effective and safe adjunctive treatment. We report a Japanese schizophrenicwoman who was not in remission with clozapine alone but with both clozapine and electroconvulsive therapy.
Abstract
Clozapine is well-known for successful use in schizophrenic patients treatment resistant to other antipsychotics. However, evenwith clozapine, 25% of schizophrenic patients are not in remission. Recently, as adjunctive treatment with clozapine, electroconvulsivetherapy has been reported to be an effective and safe adjunctive treatment. We report a Japanese schizophrenicwoman who was not in remission with clozapine alone but with both clozapine and electroconvulsive therapy.
참고문헌 (13)
- Kane J, "Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine", Arch Gen Psychiatry, 45, pp.789~796 (1988)
- Wahlbeck K, "Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials", Am J Psychiatry, 156, pp.990~999 (1999)
- Zoccali R, "The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: a double-blind, placebo-controlled study", Schizophr Res, 93, pp.109~116 (2007)
- Havaki-Kontaxaki BJ, "Concurrent administration of clozapine and electroconvulsive therapy in clozapineresistant schizophrenia", Clin Neuropharmacol, 29, pp.52~56 (2006)
- Blier P, "Lithium and clozapine-induced neutropenia", agranulocytosis, 1998, pp.13, 137~140
- Miyaoka T, "Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study", Clin Neuropharmacol, 32, pp.6~9 (2009)
- Hwang R, "Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia:replication and exploration", Prog Neuropsychopharmacol Biol Psychiatry, 37, pp.62~75 (2012)
- Melone M, "The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine", Mol Psychiatry, 6, pp.380~386 (2001)
- Matsuda KT, "Clozapine dosage, serum levels, efficacy, and side-effect profiles: a comparison of Korean-American and Caucasian patients", Psychopharmacol Bull, 32, pp.253~257 (1996)
- Chung SJ, "A retrospective study of clozapine and electroencephalographic abnormalities in schizophrenic patients", Prog Neuropsychopharmacol Biol Psychiatry, pp.139~144 (2002)
- Masoudzadeh A, "Comparative study of clozapine, electroshock and the combination of ECT with clozapine in treatment-resistant schizophrenic patients", Pak J Biol Sci, 10, pp.4287~4290 (2007)
- Dolenc TJ, "The safety of electroconvulsive therapy and lithium in combination: a case series and review of the literature", J ECT, 21, pp.165~170 (2005)
- Mukherjee S., "Combined ECT and lithium therapy", Convuls Ther, 9, pp.274~284 (1993)
